Latest Funding News

Sagalio Energy Limited reported a net cash outflow of USD 79,000 in Q4 2024, ending the quarter with only USD 42,000 in cash and limited financing facilities. The company’s funding runway now stands at just over two quarters, raising questions about its near-term financial strategy.

Perpetual Resources reports significant assay results confirming ultra-high grade spodumene at its Isabella Lithium Project and initiates metallurgical testing at the Raptor Rare Earth Project, backed by a strategic MOU with Minas Gerais government and a $1 million capital raise.

Key Petroleum Limited progresses Potential Commercial Area applications for ATPs 920 and 924 in Queensland’s Cooper Eromanga Basin, supported by a recent capital raise despite a constrained cash balance.

Oneview Healthcare reported a robust Q4 2024 cash flow update, bolstered by a significant equity raise and expanding partnerships, positioning the company for accelerated growth in 2025.

VDM Group Limited faces a complex ownership dispute over its Angolan projects, leading to halted exploration and a prolonged ASX trading suspension. Meanwhile, the company is actively pursuing new critical minerals opportunities in Australia to revive its operations.

ENRG Elements Limited reported a $586,000 net cash outflow for the December quarter, offset by a $2.02 million equity raise, boosting its cash reserves to $2.52 million.

ENRG Elements Limited has renewed key uranium exploration permits in Niger and reported outstanding trenching assay results, while securing $2.2 million in new funding to advance its projects.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

8VI Holdings Limited has confirmed its voluntary delisting from the ASX, reporting a challenging quarter marked by declining cash reserves and a strategic pivot towards preventive care that is yet to yield significant revenue.

Kalamazoo Resources reports robust assay results from its Ashburton Gold Project and secures $1.13 million in capital to fuel ongoing exploration across Western Australia and Victoria.

Kalamazoo Resources Limited reported a $449,000 net cash outflow from operating activities in Q2 2024, maintaining a cautious stance as it explores funding options to sustain its exploration efforts.

Bod Science Limited reports a modest net cash inflow of $51,000 for Q2 FY2025, supported by increased customer receipts and intellectual property sales, while navigating a complex Deed of Company Arrangement and pending acquisition.